Dapagliflozina en el paciente frágil con insuficiencia cardíaca y fracción de eyección reducida
Abstract
El artículo analiza los beneficios del tratamiento con dapagliflozina en el paciente frágil con insuficiencia cardíaca y fracción de eyección deprimida.
- Recibido: 03 Octubre 2022
- Revisión: 10 Octubre 2022
- Aceptado: 14 Octubre 2022
Citas
Vol 381 Nº21; págs. 1995-2008. 2019. McMurray JJV, Solomon SD, Inzucchi SE, et al; DAPA-HF Trial. Committees and Investigators. Dapagliflozin in patients with heart failure and reduced ejection fraction. The New England Journal of Medicine.
Vol 21 Nº5; págs. 665-675. 2019. McMurray JJV, DeMets DL, Inzucchi SE, et al; DAPA-HF. Committees and Investigators.A trial to evaluate the effect of the sodium-glucose co-transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA-HF). European Journal of Heart Failure. DOI: https://doi.org/10.1002/ejhf.1432
Vol 21 Nº11; págs. 1402-1411. 2019. McMurray JJV, DeMets DL, Inzucchi SE, et al; DAPA-HF. Committees and Investigators.The dapagliflozin and prevention of adverse-outcomes in heart failure (DAPA-HF) trial: baseline characteristics. European Journal of Heart Failure. DOI: https://doi.org/10.1002/ejhf.1548
Vol 166 Nº5; págs. 887-894. 2013. Khan H, Kalogeropoulos AP, Georgiopoulou VV, et al. Frailty and risk for heart failure in older adults: the health, aging, and body composition study. DOI: https://doi.org/10.1016/j.ahj.2013.07.032
Woods NF, LaCroix AZ, Gray SL, et al; Women's Health Initiative. Frailty: emergence and consequences in women aged 65 and older in the Women's Health Initiative Observational Study. J Am Geriatr Soc. 2005; 53:1321-30. [PMID: 16078957]
Vol 236; págs. 283-289. 2017. Denfeld QE, Winters-Stone K, Mudd JO, et al. The prevalence of frailty in heart failure: A systematic review and meta-analysis. International Jorunal of Cardiology. DOI: https://doi.org/10.1016/j.ijcard.2017.01.153
Vol 22 Nº12; págs 2314-2326. 2020. Bielecka-Dabrowa A, Ebner N, Dos Santos MR, et al. Cachexia, muscle wasting, and frailty in cardiovascular disease. European Journal of Heart Failure. DOI: https://doi.org/10.1002/ejhf.2011
Vol 22 Nº11; págs. 2123-2133. Dewan P, Jackson A, Jhund PS, et al.The prevalence and importance of frailty in heart failure with reduced ejection fraction – an analysis of PARADIGM-HF and ATMOSPHERE. European Journal of Heart Failure. DOI: https://doi.org/10.1002/ejhf.1832
MPG Journal - Política de privacidad